EODData

FRA, 3XV: XVIVO PERFUSION AB

03 Sep 2025
LAST:

15.27

CHANGE:
 0.71
OPEN:
15.27
HIGH:
15.27
ASK:
0.00
VOLUME:
930
CHG(%):
4.44
PREV:
15.98
LOW:
15.27
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 2515.2715.2715.2715.27930
02 Sep 2515.9815.9815.9815.98930
01 Sep 2515.0515.0515.0515.05930
29 Aug 2515.6615.6615.6615.66930
28 Aug 2515.5315.5315.5315.53930
27 Aug 2515.7415.7415.7415.74930
26 Aug 2515.8616.3115.8616.10930
25 Aug 2516.0616.0616.0616.06250
22 Aug 2515.6915.6915.6915.69250
21 Aug 2515.7415.7415.7415.74250

COMPANY PROFILE

Name:XVIVO PERFUSION AB
About:Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidneys with oxygenated solution for up to 24 hours; Liver Assist that provides clinicians a choice of perfusion protocols whether hypothermic, normothermic, sub-normothermic, or a combination; XVIVO System (XPS), a comprehensive ex vivo lung perfusion (EVLP) platform that offers an overview of the entire process; and STEEN Solution, a buffered extracellular solution intended for the assessment of isolated lungs after removal from the donor in preparation for eventual transplantation into a recipient. It also provides Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XPS Disposable Lung Kit that contains all the necessary devices and tubing to run a normothermic EVLP procedure on the XPS; XVIVO Organ Chamber, a sterile single-use container intended to be used as a temporary receptacle for isolated donor lungs; and XVIVO Lung Cannula Set, a sterile single-use set that connects isolated donor lungs to an extracorporeal perfusion system for ex-vivo assessment. In addition, the company offers Kidney Assist that provides clinicians with a choice of perfusion protocols from hypothermic to normothermic perfusion; and Gisto, an integrated system for organ transportation. It operates in Sweden; The Netherlands; The United States; Italy; North and South America; Asia/Pacific and Oceania; and internationally. The company was incorporated in 1998 and is headquartered in Mölndal, Sweden.
Sector:Healthcare
Address:Gemenskapens gata 9, Mölndal, Sweden, 431 53
Website:https://www.xvivogroup.com
ISIN:SE0004840718
LEI:549300G2464FYLS14B41

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

P/E Ratio:44.91
Price to Book:2.65
Price to Sales:0.59
EBITDA:95.2M
Shares:31.5M
Market Cap:481M

TECHNICAL INDICATORS

MA5:15.50
MA10:15.68
MA20:16.07
MA50:19.22
MA100:23.41
MA200:30.65
STO9:17.46
STO14:14.01
RSI14:45.95
WPR14:-85.99
MTM14:-1.31
ROC14:-0.08
ATR:0.46
Week High:15.98
Week Low:15.05
Month High:17.69
Month Low:15.05
Year High:45.89
Year Low:15.05
Volatility:48.79